Greenwich LifeSciences, Inc. (GLSI) Net Income (Loss) Attributable to Parent USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Greenwich LifeSciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
  • Greenwich LifeSciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$2.47 M, a 16.4% decline year-over-year.
  • Greenwich LifeSciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$9.24 M, a 15.8% decline year-over-year.
  • Greenwich LifeSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$8.89 M, a 13.6% decline from 2022.
  • Greenwich LifeSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.83 M, a 71.2% decline from 2021.
  • Greenwich LifeSciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.57 M, a 145% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$9.24 M -$2.47 M -$348 K -16.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$8.89 M -$2.75 M +$43.8 K +1.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-15
Q3 2023 -$8.94 M -$2.39 M -$72.8 K -3.14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-19
Q2 2023 -$8.86 M -$1.63 M -$882 K -118% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-19
Q1 2023 -$7.98 M -$2.12 M -$155 K -7.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$7.83 M -$2.79 M -$430 K -18.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-15
Q3 2022 -$7.4 M -$2.32 M -$1.46 M -169% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-19
Q2 2022 -$5.94 M -$746 K +$3.67 K +0.49% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-19
Q1 2022 -$5.94 M -$1.97 M -$1.37 M -230% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-19
Q4 2021 -$4.57 M -$2.36 M -$1.21 M -105% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.36 M -$863 K -$606 K -236% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$2.75 M -$750 K -$539 K -256% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$2.22 M -$597 K -$352 K -144% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$1.86 M -$1.15 M -$814 K -242% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 -$1.05 M -$257 K +$79.1 K +23.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.13 M -$210 K +$2.39 M +91.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$3.52 M -$245 K -$95.9 K -64.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$3.43 M -$337 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$336 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$2.6 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$149 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.